Related Experiment Video

Updated: Aug 16, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Developmental outcome of extremely preterm infants

V Y Yu1

  • 1Department of Paediatrics, Monash University, Monash Medical Centre, Melbourne, Australia.

American Journal of Perinatology
|October 7, 2000
PubMed

Insights

Perinatal centers improve survival and developmental outcomes for extremely preterm infants. Strategies like in utero transfer and surfactant therapy enhance infant survival rates and reduce long-term disability.

Area of Science:

  • Neonatal Medicine
  • Perinatal Care
  • Public Health

Background:

  • Institution-based studies show promising outcomes for extremely preterm infants within perinatal centers.
  • Population-based studies are crucial to assess the community-wide impact of perinatal-neonatal care.
  • Previous research indicated lower mortality and severe disability rates for infants born in perinatal centers.

Purpose of the Study:

  • To evaluate the impact of perinatal-neonatal care on the entire community using population-based data.
  • To examine the effectiveness of 'in utero transfer' and postnatal surfactant therapy on extremely preterm infants.

Main Methods:

  • Analysis of population-based data from a geographically defined region.
  • Comparison of outcomes for infants born within and outside perinatal centers.
  • Assessment of the impact of specific interventions like 'in utero transfer' and surfactant therapy.

Main Results:

  • Infants born within perinatal centers demonstrated significantly lower perinatal mortality and severe disability rates.
  • 'In utero transfer' was associated with substantial improvements in survival and developmental outcomes.
  • Postnatal surfactant therapy doubled survival rates for infants born at 24-26 weeks' gestation, with severe disability below 10%.

Conclusions:

  • Perinatal centers and strategies like 'in utero transfer' significantly improve outcomes for extremely preterm infants.
  • Advanced therapies such as surfactant and mechanical ventilation, despite costs, improve quality-adjusted life-years gained.
  • Population-based studies are essential for understanding the broader impact of perinatal care initiatives.

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis06:19

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...